These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 25568506)
1. Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma. Vukobrat-Bijedic Z; Husic-Selimovic A; Sofic A; Bijedic N; Bjelogrlic I; Gogov B; Mehmedovic A Med Arch; 2013 Dec; 67(6):397-401. PubMed ID: 25568506 [TBL] [Abstract][Full Text] [Related]
2. Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer? Selcukbiricik F; Bilici A; Tural D; Erdamar S; Soyluk O; Buyukunal E; Demirelli F; Serdengecti S Tumour Biol; 2013 Aug; 34(4):2233-9. PubMed ID: 23625655 [TBL] [Abstract][Full Text] [Related]
3. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694 [TBL] [Abstract][Full Text] [Related]
4. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244 [TBL] [Abstract][Full Text] [Related]
5. Serum CEA and CA19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia. Zhai H; Huang J; Yang C; Fu Y; Yang B Clin Lab; 2018 Mar; 64(3):351-356. PubMed ID: 29739122 [TBL] [Abstract][Full Text] [Related]
6. The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer. Wang RF; Song BR; Peng JJ; Cai GX; Liu FQ; Wang MH; Cai SJ; Ye X Hepatogastroenterology; 2014 Jun; 61(132):994-9. PubMed ID: 26158155 [TBL] [Abstract][Full Text] [Related]
7. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients. Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815 [TBL] [Abstract][Full Text] [Related]
8. [The pre- and postoperative monitoring of the immunological indices and tumor markers in colorectal carcinoma]. Iarŭmov N; Ignatov A; Viiachki I Khirurgiia (Sofiia); 1998; 51(3):42-8. PubMed ID: 9974027 [TBL] [Abstract][Full Text] [Related]
9. CA 19-9 as a marker in addition to CEA to monitor colorectal cancer. Stiksma J; Grootendorst DC; van der Linden PW Clin Colorectal Cancer; 2014 Dec; 13(4):239-44. PubMed ID: 25442815 [TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer. Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854 [TBL] [Abstract][Full Text] [Related]
11. The Importance of Determining Preoperative Serum Concentration of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Assessing the Progression of Colorectal Cancer. Halilovic E; Rasic I; Sofic A; Mujic A; Rovcanin A; Hodzic E; Kulovic E Med Arch; 2020 Oct; 74(5):346-349. PubMed ID: 33424087 [TBL] [Abstract][Full Text] [Related]
12. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer. Knychalski B; Lukieńczuk T Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741 [TBL] [Abstract][Full Text] [Related]
13. Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases. Peltonen R; Österlund P; Lempinen M; Nordin A; Stenman UH; Isoniemi H Tumour Biol; 2018 Jan; 40(1):1010428317752944. PubMed ID: 29378497 [TBL] [Abstract][Full Text] [Related]
14. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer. Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics. Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573 [TBL] [Abstract][Full Text] [Related]
16. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients? Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma. Zhang SY; Lin M; Zhang HB Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695 [TBL] [Abstract][Full Text] [Related]
18. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer. Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638 [TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer. Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733 [TBL] [Abstract][Full Text] [Related]
20. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]